Catalyst Pharmaceuticals, Inc. revenue increases to $85.37 million in quarter ended Mar 31, 2023 from previous quarter
By USInMinutes - May 13, 2023, 10:38 AM ET
Last Updated - Jul 18, 2023, 03:29 PM EDT
Key fundamental financials
profit of $29.57 million
Revenue of $85.37 million
earnings per share of $0.26
Current Reporting
Revenue
Net Income
Profit/Loss
Mar 2023
$85.37 million
$29.57 million
profit
Sep 2022
$0.0572 million
$0.0227 million
profit
Mar 2022
$43.09 million
$13.24 million
profit
Catalyst Pharmaceuticals, Inc. [CPRX] has reported $29.57 million profit for the fiscal quarter ending Mar 31, 2023 while the earnings for the same period were $0.26 per share.
Revenue for the quarter was $85.37 million with operating income of $35.61 million.
The Coralgables, Florida (FL)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $333.66 million.
